This HTML5 document contains 133 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n7http://dx.doi.org/10.1056/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q61948545
rdf:type
wikibase:Item
schema:description
2001年学术文章 artigo científico scienca artikolo artikel ilmiah 2001年学术文章 научная статья 2001년 논문 articolo scientifico מאמר מדעי 2001年學術文章 vitenskapelig artikkel scientific article published on 26 April 2001 article scientifique artikulong pang-agham 2001 nî lūn-bûn vědecký článek article científic 2001年学术文章 2001年学术文章 2001年學術文章 videnskabelig artikel tudományos cikk scientific article published on 26 April 2001 artigo científico научни чланак vetenskaplig artikel 2001年の論文 wissenschaftlicher Artikel სამეცნიერო სტატია article scientific наукова стаття, опублікована у квітні 2001 επιστημονικό άρθρο 2001年學術文章 naučni članak bilimsel makale مقالة علمية نشرت في 26 أبريل 2001 articol științific tieteellinen artikkeli artigo científico bài báo khoa học 2001年学术文章 teaduslik artikkel 2001年學術文章 artículu científicu научна статия scientific article published on 26 April 2001 ২৬ এপ্রিল ২০০১-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ мақолаи илмӣ artikull shkencor artykuł naukowy 2001年学术文章 artículo científico publicado en 2001 2001年學術文章 บทความทางวิทยาศาสตร์ vedecký článok vitskapeleg artikkel научни чланак wetenschappelijk artikel
p:P577
wds:Q61948545-973E4560-71E1-4D0D-8318-74A7B420B322
wdt:P577
2001-04-01T00:00:00Z
p:P407
wds:Q61948545-D3EFDC74-B1E3-45B6-9B0D-24448441DF12
wdt:P407
wd:Q1860
p:P2093
wds:Q61948545-8276E05F-2C3F-4FBD-AC6A-2B0309D7C785 wds:Q61948545-63B5FC33-AD2A-4BBC-99B2-5F2179CF6678 wds:Q61948545-74102D75-6A66-4F04-8413-0502E0B7D329 wds:Q61948545-93AB362F-2D59-4857-8023-533A6AC99E3C wds:Q61948545-876CCA23-05A1-40ED-8404-6DAACF8A3CDA wds:Q61948545-906F4FC1-B59D-4A24-B8C7-B73C25EE98B7 wds:Q61948545-AB6C2B67-839B-4055-B3EE-A304D56CCED5 wds:Q61948545-AEF4E861-BA0D-4B80-AABD-2139A5B1DE8C wds:Q61948545-D8FD48E3-82C6-48A7-BF69-5B3A5D1A08DC wds:Q61948545-DB5B0374-8F7F-4974-A415-524FE77B009A wds:Q61948545-17593EF3-4FC1-4F9F-9F49-7B6AADC29D09 wds:Q61948545-034DCF2C-CF20-45F4-B71C-2D96F9060C01 wds:Q61948545-2F1CBD62-7261-40FC-8EB0-B69AF06948C2 wds:Q61948545-360C2655-DB45-4B6B-8A80-2187D30AE26B wds:Q61948545-E8069DFA-E42F-4E3F-8A97-1521DFDDDCC6 wds:Q61948545-E054ED69-6682-4013-9D18-223AB1EFC331 wds:Q61948545-E37EC463-C679-40AE-B84E-D02D434D7865 wds:Q61948545-FAEDF935-D74A-4474-940A-D0FC775439FD
wdt:P2093
Michael J. Labellarte James Robinson John T. Walkup Thomas O'Hara Brian Klee Mark Davies Mark A. Riddle Michael Sweeney Margaret Roper John Piacentini Sabine Hack John March Lindsey Bergman Louise Ritz Scott Compton Sherryl Baker James McCracken Daniel S. Pine
rdfs:label
Fluvoxamine for the Treatment of Anxiety Disorders in Children and Adolescents Fluvoxamine for the Treatment of Anxiety Disorders in Children and Adolescents
skos:prefLabel
Fluvoxamine for the Treatment of Anxiety Disorders in Children and Adolescents Fluvoxamine for the Treatment of Anxiety Disorders in Children and Adolescents
schema:name
Fluvoxamine for the Treatment of Anxiety Disorders in Children and Adolescents Fluvoxamine for the Treatment of Anxiety Disorders in Children and Adolescents
p:P50
wds:Q61948545-9414FF03-C3A8-43B6-B4F2-2A7D13AAABBD wds:Q61948545-5F6F36D8-38E2-4E36-A529-3B4456267636 wds:Q61948545-62054686-1F9F-4A96-B4B8-B6849B272726 wds:Q61948545-1AF3F56A-287A-46F4-B07F-705821B53A7F
wdt:P50
wd:Q92372542 wd:Q109443804 wd:Q109420186 wd:Q109440877
p:P1476
wds:Q61948545-4D30768B-567D-4715-AE83-E92460D581E5
wdt:P1476
Fluvoxamine for the treatment of anxiety disorders in children and adolescents. The Research Unit on Pediatric Psychopharmacology Anxiety Study Group
p:P304
wds:Q61948545-829205AD-82D2-44F0-8188-5897CB202BC4
wdt:P304
1279-1285
p:P31
wds:Q61948545-E53F3B36-2480-4096-B301-61602A53A816
wdt:P31
wd:Q13442814
p:P921
wds:Q61948545-947A0432-FF08-4818-B7C0-661042799DED
wdt:P921
wd:Q409236
p:P698
wds:Q61948545-0B0017FC-3FB7-460F-A864-007C7BC1DB66
wdtn:P698
n10:11323729
wdt:P698
11323729
p:P1433
wds:Q61948545-CC5569AB-B8AC-4987-9DEC-F00558BA0214
wdt:P1433
wd:Q582728
p:P433
wds:Q61948545-2B0BE1F4-9D7F-4F45-AF07-F581C1DAE1D1
p:P478
wds:Q61948545-5153F50F-4043-4D7A-B5A4-E8D9656E8928
wdt:P433
17
wdt:P478
344
p:P356
wds:Q61948545-26E239DB-D460-450D-B9D7-DF4236652FE4
wdtn:P356
n7:NEJM200104263441703
wdt:P356
10.1056/NEJM200104263441703